IRCT20160118026097N3招募中3 期
Evaluation of interferon treatment in high-risk covid19 patients in Qom
Ghoum University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Laboratory confirmation of Covid19 infection with reverse transcription polymerase chain reaction (RT-PCR) from any diagnostic sampling source
- •A new organ dysfunction related to Covid19
- •Being an adult
排除标准
- •Intention to commit suicide (interfering with interferon (IFN) -b1b).
- •Sensitivity or sensitivity reaction to Lupinavir / Ritonavir or IFN-ß1b recombinant, including toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema or angioedema syndrome.
- •ALT above 5 times normal
- •Use of drugs that are contraindicated with lopinavir / ritonavir and should not be substituted or discontinued during the study period, such as CYP3A inhibitors.
- •pregnancy.Eligible female participants are tested at gestational age before enrolling in the study for pregnancy.
- •Vulnerable groups
研究者
相似试验
招募中
不适用
Efficacy of interferon therapy for recurrence-free and overall survival after curative radiofrequency ablation for HCV-related hepatocellular carcinoma.hepatocellular carcinomaJPRN-UMIN000006761Kyoundo hospital50
招募中
不适用
Efficacy and safety of interferon-free treatment in patients with chronic hepatitis Cchronic hepatitis CJPRN-UMIN000037575Osaka university1,000
已完成
4 期
Response-Guided Interferon Therapy for patients with chronic hepatitis C of the Genotype 1 high viral load: Japanese multi-center, randomized controlled study: (ReGIT-J study)Chronic hepatitis CJPRN-UMIN000002748Hyogo College Of Medicine300
已完成
不适用
Clinical Significance of Monitoring by Interferon-Gamma Releasing Assay (IGRA) in Patients with Non-Small Cell Lung Cancer receiving Checkpoint Inhibitor Treatmenton-Small Cell Lung CancerJPRN-UMIN000031881Osaka Prefectural Hospital Organization Osaka Habikino Medical Center30
招募中
不适用
Analysis of efficacy and safety of interferon-free therapy for recurrent hepatitis C after liver transplantatiohepatitis C after liver transplantationJPRN-UMIN000018759Kyoto University Hospital50